Analysis of drug-protein binding using on-line immunoextraction and high-performance affinity microcolumns: Studies with normal and glycated human serum albumin

Ryan Matsuda, Donald Jobe, Jared Beyersdorf, David S. Hage

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

A method combining on-line immunoextraction microcolumns with high-performance affinity chromatography (HPAC) was developed and tested for use in examining drug-protein interactions with normal or modified proteins. Normal human serum albumin (HSA) and glycated HSA were used as model proteins for this work. High-performance immunoextraction microcolumns with sizes of 1.0-2.0 cm × 2.1 mm i.d and containing anti-HSA polyclonal antibodies were developed and tested for their ability to bind normal HSA or glycated HSA. These microcolumns were able to extract up to 82-93% for either type of protein at 0.05-0.10 mL/min and had a binding capacity of 0.34-0.42 nmol HSA for a 1.0 cm × 2.1 mm i.d microcolumn. The immunoextraction microcolumns and their adsorbed proteins were tested for use in various approaches for drug binding studies. Frontal analysis was used with the adsorbed HSA/glycated HSA to measure the overall affinities of these proteins for the drugs warfarin and gliclazide, giving comparable values to those obtained previously using similar protein preparations that had been covalently immobilized within HPAC columns. Zonal elution competition studies with gliclazide were next performed to examine the specific interactions of this drug at Sudlow sites I and II of the adsorbed proteins. These results were also comparable to those noted in prior work with covalently immobilized samples of normal HSA or glycated HSA. These experiments indicated that drug-protein binding studies can be carried out by using on-line immunoextraction microcolumns with HPAC. The same method could be used in the future with clinical samples and other drugs or proteins of interest in pharmaceutical studies or biomedical research.

Original languageEnglish (US)
Pages (from-to)112-120
Number of pages9
JournalJournal of Chromatography A
Volume1416
DOIs
StatePublished - Oct 16 2015

Fingerprint

Protein Binding
Serum Albumin
Pharmaceutical Preparations
Affinity chromatography
Proteins
Affinity Chromatography
Gliclazide
Drug Interactions
Warfarin
Biomedical Research
Antibodies

Keywords

  • Affinity microcolumn
  • Drug-protein binding
  • Glycation
  • High-performance affinity chromatography
  • Human serum albumin
  • Immunoextraction

ASJC Scopus subject areas

  • Analytical Chemistry
  • Biochemistry
  • Organic Chemistry

Cite this

Analysis of drug-protein binding using on-line immunoextraction and high-performance affinity microcolumns : Studies with normal and glycated human serum albumin. / Matsuda, Ryan; Jobe, Donald; Beyersdorf, Jared; Hage, David S.

In: Journal of Chromatography A, Vol. 1416, 16.10.2015, p. 112-120.

Research output: Contribution to journalArticle

@article{2c250e1a64364f3e9823d98329bafc26,
title = "Analysis of drug-protein binding using on-line immunoextraction and high-performance affinity microcolumns: Studies with normal and glycated human serum albumin",
abstract = "A method combining on-line immunoextraction microcolumns with high-performance affinity chromatography (HPAC) was developed and tested for use in examining drug-protein interactions with normal or modified proteins. Normal human serum albumin (HSA) and glycated HSA were used as model proteins for this work. High-performance immunoextraction microcolumns with sizes of 1.0-2.0 cm × 2.1 mm i.d and containing anti-HSA polyclonal antibodies were developed and tested for their ability to bind normal HSA or glycated HSA. These microcolumns were able to extract up to 82-93{\%} for either type of protein at 0.05-0.10 mL/min and had a binding capacity of 0.34-0.42 nmol HSA for a 1.0 cm × 2.1 mm i.d microcolumn. The immunoextraction microcolumns and their adsorbed proteins were tested for use in various approaches for drug binding studies. Frontal analysis was used with the adsorbed HSA/glycated HSA to measure the overall affinities of these proteins for the drugs warfarin and gliclazide, giving comparable values to those obtained previously using similar protein preparations that had been covalently immobilized within HPAC columns. Zonal elution competition studies with gliclazide were next performed to examine the specific interactions of this drug at Sudlow sites I and II of the adsorbed proteins. These results were also comparable to those noted in prior work with covalently immobilized samples of normal HSA or glycated HSA. These experiments indicated that drug-protein binding studies can be carried out by using on-line immunoextraction microcolumns with HPAC. The same method could be used in the future with clinical samples and other drugs or proteins of interest in pharmaceutical studies or biomedical research.",
keywords = "Affinity microcolumn, Drug-protein binding, Glycation, High-performance affinity chromatography, Human serum albumin, Immunoextraction",
author = "Ryan Matsuda and Donald Jobe and Jared Beyersdorf and Hage, {David S.}",
year = "2015",
month = "10",
day = "16",
doi = "10.1016/j.chroma.2015.09.023",
language = "English (US)",
volume = "1416",
pages = "112--120",
journal = "Journal of Chromatography A",
issn = "0021-9673",

}

TY - JOUR

T1 - Analysis of drug-protein binding using on-line immunoextraction and high-performance affinity microcolumns

T2 - Studies with normal and glycated human serum albumin

AU - Matsuda, Ryan

AU - Jobe, Donald

AU - Beyersdorf, Jared

AU - Hage, David S.

PY - 2015/10/16

Y1 - 2015/10/16

N2 - A method combining on-line immunoextraction microcolumns with high-performance affinity chromatography (HPAC) was developed and tested for use in examining drug-protein interactions with normal or modified proteins. Normal human serum albumin (HSA) and glycated HSA were used as model proteins for this work. High-performance immunoextraction microcolumns with sizes of 1.0-2.0 cm × 2.1 mm i.d and containing anti-HSA polyclonal antibodies were developed and tested for their ability to bind normal HSA or glycated HSA. These microcolumns were able to extract up to 82-93% for either type of protein at 0.05-0.10 mL/min and had a binding capacity of 0.34-0.42 nmol HSA for a 1.0 cm × 2.1 mm i.d microcolumn. The immunoextraction microcolumns and their adsorbed proteins were tested for use in various approaches for drug binding studies. Frontal analysis was used with the adsorbed HSA/glycated HSA to measure the overall affinities of these proteins for the drugs warfarin and gliclazide, giving comparable values to those obtained previously using similar protein preparations that had been covalently immobilized within HPAC columns. Zonal elution competition studies with gliclazide were next performed to examine the specific interactions of this drug at Sudlow sites I and II of the adsorbed proteins. These results were also comparable to those noted in prior work with covalently immobilized samples of normal HSA or glycated HSA. These experiments indicated that drug-protein binding studies can be carried out by using on-line immunoextraction microcolumns with HPAC. The same method could be used in the future with clinical samples and other drugs or proteins of interest in pharmaceutical studies or biomedical research.

AB - A method combining on-line immunoextraction microcolumns with high-performance affinity chromatography (HPAC) was developed and tested for use in examining drug-protein interactions with normal or modified proteins. Normal human serum albumin (HSA) and glycated HSA were used as model proteins for this work. High-performance immunoextraction microcolumns with sizes of 1.0-2.0 cm × 2.1 mm i.d and containing anti-HSA polyclonal antibodies were developed and tested for their ability to bind normal HSA or glycated HSA. These microcolumns were able to extract up to 82-93% for either type of protein at 0.05-0.10 mL/min and had a binding capacity of 0.34-0.42 nmol HSA for a 1.0 cm × 2.1 mm i.d microcolumn. The immunoextraction microcolumns and their adsorbed proteins were tested for use in various approaches for drug binding studies. Frontal analysis was used with the adsorbed HSA/glycated HSA to measure the overall affinities of these proteins for the drugs warfarin and gliclazide, giving comparable values to those obtained previously using similar protein preparations that had been covalently immobilized within HPAC columns. Zonal elution competition studies with gliclazide were next performed to examine the specific interactions of this drug at Sudlow sites I and II of the adsorbed proteins. These results were also comparable to those noted in prior work with covalently immobilized samples of normal HSA or glycated HSA. These experiments indicated that drug-protein binding studies can be carried out by using on-line immunoextraction microcolumns with HPAC. The same method could be used in the future with clinical samples and other drugs or proteins of interest in pharmaceutical studies or biomedical research.

KW - Affinity microcolumn

KW - Drug-protein binding

KW - Glycation

KW - High-performance affinity chromatography

KW - Human serum albumin

KW - Immunoextraction

UR - http://www.scopus.com/inward/record.url?scp=84942191340&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84942191340&partnerID=8YFLogxK

U2 - 10.1016/j.chroma.2015.09.023

DO - 10.1016/j.chroma.2015.09.023

M3 - Article

C2 - 26381571

AN - SCOPUS:84942191340

VL - 1416

SP - 112

EP - 120

JO - Journal of Chromatography A

JF - Journal of Chromatography A

SN - 0021-9673

ER -